Formulations for Non-invasive Delivery of Active Proteins to an Animal or Human
This invention relates to formulations which contain at least one active peptide intended to be used for prevention or treatment of a condition in an animal or human. Said active peptide has been expressed in a system that improves the conservation of those properties essential to the prophylactic o...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
01.10.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This invention relates to formulations which contain at least one active peptide intended to be used for prevention or treatment of a condition in an animal or human. Said active peptide has been expressed in a system that improves the conservation of those properties essential to the prophylactic or therapeutic effect of said peptide before and after delivery to an animal or human and until the peptide delivers its activity at the effector site within said animal or human. The invention is particularly relevant to formulations of oral or mucosal vaccines or biopharmaceuticals. The active peptide of the formulation is recombinantly expressed in cells or whole animals. In a preferred embodiment of this invention the active polypeptide of the formulation has been recombinantly expressed in insect cells or whole insect larvae. |
---|---|
Bibliography: | Application Number: US201214386758 |